Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学TROP2 ADC, Bladder/GYN Cancer

Vandana Abramson

MD

🏢Vanderbilt-Ingram Cancer Center🌐USA

Associate Professor of Medicine

29
h-index
0
Key Papers
0
Key Contributions

👥Biography 个人简介

Dr. Vandana Abramson is a breast and thoracic oncologist who has expanded TROP2 ADC research into bladder and gynecologic malignancies. She has contributed to TROPHY-U-01 evaluating sacituzumab govitecan in urothelial cancer and has participated in TROP2 ADC studies in endometrial and cervical cancer. Her work broadens the clinical application of TROP2-targeted therapy across epithelial tumor types.

Share:

🧪Research Fields 研究领域

TROP2 bladder urothelial ADC
TROP2 endometrial cancer
TROPHY-U-01 sacituzumab urothelial
TROP2 pan-gynecologic
breast cancer TNBC clinical trials

🎓Key Contributions 主要贡献

Representative Works 代表性著作

📄Data Sources 数据来源

Last updated: 2026-04-01 | All information from publicly available academic sources

关注 Vandana Abramson 的研究动态

Follow Vandana Abramson's research updates

留下邮箱,当我们发布与 Vandana Abramson(Vanderbilt-Ingram Cancer Center)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment